Winn-Dixie has selected IBM point-of-sale and self-checkout technology to help transform customer service, speed innovation and increase the operational efficiency of 484 Winn-Dixie store locations and other store formats across the southeastern United States, IBM reported.
While Indian generic drug maker Ranbaxy Labs is expected by many to launch a generic version of a cholesterol drug made by Pfizer later this year, it may have to sell its rights to it if it can't win Food and Drug Administration approval in time, according to published reports.
Five tobacco companies filed suit against the Food and Drug Administration challenging nine new cigarette warnings as an unconstitutional way of forcing tobacco manufacturers to disseminate the government's anti-smoking message.
Those within the mass-market beauty industry are wise not to rest on their laurels, as research indicates that sales of prestige makeup and skin care in U.S. department stores surpassed pre-recession volume in the first half of 2011, according to market research company the NPD Group.
The National Advertising Division of the Council of Better Business Bureaus on Tuesday determined Chattem, maker of the Allegra allergy relief medication, provided a reasonable basis for the claim that “only Allegra combines fast, non-drowsy, 24-hour relief.”
Mandatory mail seems to cause some patients to prematurely discontinue therapy, especially among those patients without previous mail-service pharmacy experience. At least, that’s what a recent study on mandatory mail suggested.